Keyphrases
Radiotherapy
100%
Chemoradiotherapy
100%
Locoregional Recurrence
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Effective Treatment
50%
Survival Rate
50%
Chemotherapy
50%
Surgical Resection
50%
Median Survival Time
50%
Treatment Modalities
50%
Safe Treatment
50%
Postsurgical
50%
Late Toxicity
50%
Locoregional
50%
Acute Toxicity
50%
3-year Survival
50%
Recurrence Treatment
50%
Severe Acute
50%
Recurrent Non-small Cell Lung Cancer
50%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Chemoradiation Therapy
100%
Non Small Cell Lung Cancer
100%
Chemotherapy
33%
Survival Rate
33%
Median Survival Time
33%
Immunology and Microbiology
Survival Rate
100%
Median Survival Time
100%